相关实验视频
Updated: Jul 11, 2025

06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
2.6K
通过纳米工程提高维生素的生物可用性及其应用:最新情况
Sadhna Mishra1,2, Shalini Sahani3, Shikha Pandhi2
1Faculty of Agricultural Sciences, GLA University, Mathura-281406, India.
Current pharmaceutical biotechnology
|November 8, 2023
概括
维生素纳米工程增强稳定性和生物可用性使用纳米结构,如纳米粒子和纳米脂质体. 对于这些先进的交付系统,仔细的安全评估至关重要.
科学领域:
- 纳米技术 纳米技术
- 营养科学 营养科学
- 材料科学 材料科学 材料科学
背景情况:
- 传统的维生素配方往往在稳定性,生物可用性和保质期方面面临限制.
- 纳米工程通过先进的封装技术提供了新的方法来克服这些挑战.
研究的目的:
- 审查维生素纳米工程和封装策略的最新进展.
- 探索各种纳米结构对维生素生物可用性和稳定性的影响.
- 提供关于选择适当的纳米结构来增强维生素输送的见解.
主要方法:
- 关于维生素纳米工程技术的文学综合评论.
- 分析不同的纳米结构,包括纳米纤维,纳米凝,纳米颗粒和纳米脂质体.
- 探索纳米结构形式的维生素生物可用性 (维生素B,C,E,A,D).
主要成果:
- 纳米工程显著改善了维生素的稳定性,生物可用性,保质期和整体功能.
- 各种纳米结构显示出各种维生素的高封装效率.
- 了解纳米形式的分子相互作用是优化交付的关键.
结论:
- 纳米封装是提高维生素有效性和稳定性的有希望的策略.
- 精心选择纳米材料和严格的安全评估是必不可少的.
- 需要进一步的长期研究来解决纳米结构的潜在安全问题.
相关概念视频
Factors Influencing Bioavailability: First-Pass Elimination
6.4K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.4K
Bioavailability: Overview
2.8K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.8K
Factors Affecting Dissolution: Particle Size and Effective Surface Area
860
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
860
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
209
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
209

